ANELLODESIGN
DEAD

Serial Number

97269150

Owner

RING THERAPEUTICS, INC.

Attorney

Christina M. Licursi

Filing Date

Feb 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ANELLODESIGN Trademark

Serial Number: 97269150

ANELLODESIGN is a trademark filed by RING THERAPEUTICS, INC. on February 16, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

RING THERAPEUTICS, INC. (19 trademarks)

CAMBRIDGE, MA 02142

Entity Type: 03

Trademark Details

Filing Date

February 16, 2022

Registration Date

Not Registered

Published for Opposition

March 21, 2023

Goods & Services

Downloadable software for the discovery, capture, and analysis of data in the field of anelloviruses; downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical research and anellovirsues; downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development

Product development for others in the field of biotechnology and development of pharmaceuticals and therapeutic agents; research and development of therapeutics related to the discovery, capture, and analysis of data in the field of anelloviruses; laboratory services for the discovery, capture, and analysis of data in the field of anelloviruses; providing online non-downloadable software for the discovery, capture, and analysis of data in the field of anelloviruses; providing temporary use of on-line non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical research and anelloviruses; providing temporary use of on-line non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic product

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 16, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 16, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 25, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jan 24, 2025 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 30, 2024 AITU
SOU EXTENSION 3 FILED
Nov 14, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 14, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 15, 2024 EXRA
SOU EXTENSION 2 GRANTED
May 14, 2024 EX2G
SOU EXTENSION 2 FILED
May 14, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
May 14, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 26, 2023 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 26, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 26, 2023 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 14, 2023 EXRA
SOU EXTENSION 1 GRANTED
Nov 10, 2023 EX1G
SOU EXTENSION 1 FILED
Nov 10, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 10, 2023 EEXT
ASSIGNED TO EXAMINER
Nov 7, 2023 DOCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 16, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 21, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 21, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 1, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 13, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 24, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 1, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 1, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 1, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 1, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 22, 2022 NWOS